Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2026 07:05 ET | Source: AC Immune SA

AC Immune First Quarter 2026 Financial and Corporate Updates

AC Immune First Quarter 2026 Financial and Corporate Updates Dosed first subjects in Phase 1 trial of brain-penetrant small molecule NLRP3 inhibitor ACI-19764 with SAD/MAD results in healthy...
April 30, 2026 07:03 ET | Source: Research and Markets

mRNA Therapeutics CDMO Market Analysis Report 2026: $8.25+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics CDMO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The mRNA therapeutics CDMO market is experiencing...
April 30, 2026 07:00 ET | Source: NetraMark Holdings Inc.

NetraMark To Open The Market At The Toronto Stock Exchange On May 5, 2026

TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a company developing advanced artificial intelligence...
April 30, 2026 06:40 ET | Source: Research and Markets

Companion Animal Pharmaceuticals Market Analysis Report 2026: $29.14 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Companion Animal Pharmaceuticals Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global companion animal...
April 29, 2026 16:05 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Announces Initiative to Support Operational Efficiency and Cost Reduction

Autolus announced a strategic initiative and plan to improve operational efficiency and reduce operating expenses.
April 29, 2026 16:05 ET | Source: Relay Therapeutics, Inc.

Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026

CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing...
April 29, 2026 16:05 ET | Source: AVITA Medical

AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO

AVITA Medical announces TGA certification of RECELL GO in Australia for burn and acute wound treatment, advancing Spray-On Skin technology
April 29, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight

New York, USA, April 29, 2026 (GLOBE NEWSWIRE) -- Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight The metagenomics sequencing market is...
April 29, 2026 11:36 ET | Source: Research and Markets

AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, Chemaxon - Global Forecast to 2030 and 2035

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "AI in Predictive Toxicology Market Report 2026" has been added to ResearchAndMarkets.com's offering. The artificial intelligence (AI) in...
April 29, 2026 11:25 ET | Source: Research and Markets

Pet Cancer Therapeutics Research Report 2026: $720 Mn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Pet Cancer Therapeutics Market Report 2026" has been added to ResearchAndMarkets.com's offering. The pet cancer therapeutics market has notably...